Search Results - "Gay, M L"

Comprehensive genomic profiles of metastatic and relapsed salivary gland carcinomas are associated with tumor type and reveal new routes to targeted therapies by Ross, J.S., Gay, L.M., Wang, K., Vergilio, J.A., Suh, J., Ramkissoon, S., Somerset, H., Johnson, J.M., Russell, J., Ali, S., Schrock, A.B., Fabrizio, D., Frampton, G., Miller, V., Stephens, P.J., Elvin, J.A., Bowles, D.W.

“…Relapsed/metastatic salivary gland carcinomas (SGCs) have a wide diversity of histologic subtypes associated with variable clinical aggressiveness and response…”
Get full text

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer by Hartmaier, R.J., Trabucco, S.E., Priedigkeit, N., Chung, J.H., Parachoniak, C.A., Vanden Borre, P., Morley, S., Rosenzweig, M., Gay, L.M., Goldberg, M.E., Suh, J., Ali, S.M., Ross, J., Leyland-Jones, B., Young, B., Williams, C., Park, B., Tsai, M., Haley, B., Peguero, J., Callahan, R.D., Sachelarie, I., Cho, J., Atkinson, J.M., Bahreini, A., Nagle, A.M., Puhalla, S.L., Watters, R.J., Erdogan-Yildirim, Z., Cao, L., Oesterreich, S., Mathew, A., Lucas, P.C., Davidson, N.E., Brufsky, A.M., Frampton, G.M., Stephens, P.J., Chmielecki, J., Lee, A.V.

“…Estrogen receptor-positive (ER-positive) metastatic breast cancer is often intractable due to endocrine therapy resistance. Although ESR1 promoter switching…”
Get full text

Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancer by Chung, J.H., Pavlick, D., Hartmaier, R., Schrock, A.B., Young, L., Forcier, B., Ye, P., Levin, M.K., Goldberg, M., Burris, H., Gay, L.M., Hoffman, A.D., Stephens, P.J., Frampton, G.M., Lipson, D.M., Nguyen, D.M., Ganesan, S., Park, B.H., Vahdat, L.T., Leyland-Jones, B., Mughal, T.I., Pusztai, L., O’Shaughnessy, J., Miller, V.A., Ross, J.S., Ali, S.M.

“…Genomic changes that occur in breast cancer during the course of disease have been informed by sequencing of primary and metastatic tumor tissue. For patients…”
Get full text

Comprehensive profiling and molecularly guided therapy (MGT) for carcinomas of unknown primary (CUP): CUPISCO: A phase II, randomised, multicentre study comparing targeted therapy or immunotherapy with standard platinum-based chemotherapy by Krämer, A, Losa, F, Gay, L M, Page, D R, Foser, S, Mughal, T I, Ross, J S, Baciarello, G, Mileshkin, L R, Osborne, S, Moch, H

Get full text

Pan-cancer analysis of ret fusions (FN) and rearrangements (RE) by genomic profiling of 158,360 tumors by Gay, L.M., Pavlick, D.C., Ramkissoon, S., Daniel, S., Killian, J.K., Vergilio, J.-A., Severson, E., Frampton, G.M., Elvin, J.A., Ross, J.S.

Get full text

Comprehensive genomic profiling (CGP) of chemotherapy-resistant, primary mediastinal nonseminomatous germ cell tumors (PMNSGCT) by Necchi, A., Bratslavsky, G., Corona, R.J., Chung, J., Millis, S.Z., Gay, L.M., Elvin, J.-A., Vergilio, J.-A., Ramkissoon, S., Severson, E., Daniel, S., Killian, J.K., Ali, S.M., Schrock, A.B., Miller, V.A., Ross, J.S.

Get full text

Prospective comprehensive genomic profiling (CGP) of 3,343 primary and metastatic site prostate tumors by Ali, S.M., Chung, J., Dewal, N., Gay, L.M., He, Y., Sokol, E.S., Millis, S.Z., Killian, J.K., Schrock, A.B., Pal, S.K., Miller, V.A., Ross, J.S., Agarwal, N.

Get full text

Recurrent and metastatic carcinomas of the lacrimal gland: High frequency of ERBB2 driven disease by Girard, N., Corona, R.J., Chung, J., Millis, S.Z., Gay, L.M., Elvin, J.A., Vergilio, J.-A., Ramkissoon, S., Severson, E., Daniel, S., Killian, J.K., Ali, S.M., Schrock, A.B., Miller, V.A., Ross, J.S.

Get full text

Interphase cytogenetics in paraffin sections of lung tumors by non- isotopic in situ hybridization. Mapping genotype/phenotype heterogeneity by Kim, SY, Lee, JS, Ro, JY, Gay, ML, Hong, WK, Hittelman, WN

“…To better understand the relationship between specific chromosome changes found in human lung tumors and their phenotypic consequences at the tissue level, an…”
Get full text

Rugged LC-MS/MS Survey Analysis for Acrylamide in Foods by Roach, John A. G, Andrzejewski, Denis, Gay, Martha L, Nortrup, David, Musser, Steven M

“…The described liquid chromatography−tandem mass spectrometry (LC-MS/MS) method for the detection of acrylamide in food entails aqueous room temperature…”
Get full text

Detection of chromosomal polysomy in oral leukoplakia, a premalignant lesion by Lee, J S, Kim, S Y, Hong, W K, Lippman, S M, Ro, J Y, Gay, M L, Hittelman, W N

Get more information

Identification of a New Series of Fumonisins Containing 3-Hydroxypyridine by Musser, Steven M, Gay, Martha L, Mazzola, Eugene P, Plattner, Ronald D

“…A new series of fumonisins, designated FP1-3, were isolated from a culture of Fusarium moniliforme (M-2285) grown on solid corn. The new compounds contain a…”
Get full text

Chiral gas chromatographic determination of ephedrine-type alkaloids in dietary supplements containing Ma Huang by Betz, J.M. (US Food and Drug Administration, Washington, DC.), Gay, M.L, Mossoba, M.M, Adams, S, Portz, B.S

“…Ma Huang is a traditional Chinese medicine derived from the aerial parts of several Ephedra species (Ephedraceae). These plants produce (-)-ephedrine,…”
Get full text

Structure/function studies of Ser/Thr and Tyr protein phosphorylation in Mycobacterium tuberculosis by Greenstein, Andrew E, Grundner, Christoph, Echols, Nathaniel, Gay, Laurie M, Lombana, T Noelle, Miecskowski, Carl A, Pullen, Kristi E, Sung, Pei-Yi, Alber, Tom

“…Many bacterial species express 'eukaryotic-like' Ser/Thr or Tyr protein kinases and phosphatases that are candidate mediators of developmental changes and…”
Get more information

Determination of Ephedrine Alkaloids in Dietary Supplement Standard Reference Materials by Sander, Lane C, Sharpless, Katherine E, Satterfield, Mary B, Ihara, Toshihide, Phinney, Karen W, Yen, James H, Wise, Stephen A, Gay, Martha L, Lam, Joseph W, McCooeye, Margaret, Gardner, Graeme, Fraser, Catharine, Sturgeon, Ralph, Roman, Mark

“…A suite of five ephedra-containing dietary supplement Standard Reference Materials (SRMs) has been issued by the National Institute of Standards and Technology…”
Get full text

Voice therapy techniques adapted to treatment of habit cough: a pilot study by Blager, F B, Gay, M L, Wood, R P

“…Patients with long-standing habit cough having no organic basis can be successfully treated with a combination of psychotherapy and speech therapy. Techniques…”
Get more information

445TiPComprehensive profiling and molecularly guided therapy (MGT) for carcinomas of unknown primary (CUP): CUPISCO: A phase II, randomised, multicentre study comparing targeted therapy or immunotherapy with standard platinum-based chemotherapy by Krämer, A, Losa, F, Gay, L M, Page, D R, Foser, S, Mughal, T I, Ross, J S, Baciarello, G, Mileshkin, L R, Osborne, S, Moch, H

Get full text

58PDPan-cancer analysis of ret fusions (FN) and rearrangements (RE) by genomic profiling of 158,360 tumors by Gay, L M, Pavlick, D C, Ramkissoon, S, Daniel, S, Killian, J K, Vergilio, J-A, Severson, E, Frampton, G M, Elvin, J A, Ross, J S

Get full text

1983PD_PRComprehensive genomic profiling (CGP) of carcinoma of unknown primary origin (CUP): Retrospective molecular classification of potentially eligible patients (pts) for targeted or immunotherapy treatment (tx) using the prospective CUPISCO trial’s criteria by Ross, J S, Sokol, E S, Moch, H, Mileshkin, L, Baciarello, G, Losa, F, Beringer, A, Thomas, M, Foser, S, Elvin, J, Danziger, N, Ngo, N, Tse, J Y, Killian, K, Jin, D X, Gay, L M, Krämer, A

“…Abstract Background Standard CUP therapy has not changed for decades. CUPISCO (NCT03498521) is an ongoing randomised prospective trial using CGP to assign CUP…”
Get full text

151PRecurrent and metastatic carcinomas of the lacrimal gland: High frequency of ERBB2 driven disease by Girard, N, Corona, R J, Chung, J, Millis, S Z, Gay, L M, Elvin, J A, Vergilio, J-A, Ramkissoon, S, Severson, E, Daniel, S, Killian, J K, Ali, S M, Schrock, A B, Miller, V A, Ross, J S

Get full text